5
(Based on Use in Commerce) SWALLOW-FACILITATING FORMULATION SOLD AS AN INTEGRAL COMPONENT OF PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASE OR HEALTH-RELATED CONDITIONS INVOLVING BLOOD AND BLOOD-FORMING ORGANS, THE CARDIAC CIRCULATORY SYSTEMS, THE PERIPHERAL VASCULAR CIRCULATORY SYSTEM, THE ENDOCRINE SYSTEM, THE GENITOURINARY SYSTEM, THE IMMUNE SYSTEM, INFECTIOUS AND PARASITIC CONDITIONS, THE UPPER AND LOWER DIGESTIVE SYSTEM, MENTAL DISORDERS, METABOLIC DISORDERS, MULTI-SYSTEM AND ILL-DEFINED CONDITIONS, MUSCULOSKELETAL SYSTEMS AND CONNECTIVE TISSUE, NEOPLASMS, THE NERVOUS SYSTEM, NUTRITIONAL DISORDERS, PREGNANCY, THE RESPIRATORY SYSTEM, SENSORY ORGAN CONDITIONS, SKIN AND SUBCUTANEOUS CONDITIONS
40
(Based on Section 44(e) only) MANUFACTURE OF RAPIDLY DISSOLVING PHARMACEUTICAL PRODUCTS TO THE ORDER OR SPECIFICATION OF OTHERS
42
(Based on Section 44(e) only) RESEARCH AND DEVELOPMENT OF RAPIDLY DISSOLVING PHARMACEUTICAL PRODUCTS AND TECHNOLOGIES FOR OTHERS, AND PHARMACEUTICAL PRODUCT CONSULTATION REGARDING THE TESTING, EVALUATING, OR RESEARCHING OF PHARMACEUTICAL PRODUCTS
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen